By
Trending Posts
At VivaTech 2025, Can NVIDIA, Sanofi, and TetraScience…
Key Highlights The 20-Exabyte Problem: Data, Not Models, Is the Limiting FactorAt The Rise of Scientific AI panel…
Is AstraZeneca’s $20M AI Hub in Bengaluru the…
Key Highlights Strategic Investment to Scale AI-Driven InnovationAstraZeneca has inaugurated a state-of-the-art Global Hub in Bengaluru with an…
Will Samsung’s Acquisition of Xealth Spark a New…
Key Highlights Samsung Expands into AI Healthcare with Xealth DealSamsung Electronics has announced its acquisition of Xealth, a…
Can Lisata Therapeutics and GATC Health’s AI Breakthrough…
Key Highlights AI-Powered Drug Discovery Moves Toward the Clinic with OUD FocusLisata Therapeutics and GATC Health have expanded…
Is Merck’s $10B Acquisition of Verona a Strategic…
Key Highlights Merck Secures Verona to Bridge Its Post-Keytruda Future Merck & Co. has taken a bold step…
Can Google DeepMind’s Isomorphic Labs Revolutionize Clinical Trials…
Key Takeaways AI to Clinic: Isomorphic Labs Moves Beyond Design to Human TrialsIsomorphic Labs, the AI drug discovery…
Five Breakthrough AI Innovations Set to Transform Healthcare…
The healthcare industry is poised for a major transformation in 2025 as artificial intelligence (AI) technologies continue to…
Biomni AI Agent Unveils New Era in Biology…
A groundbreaking advancement in life sciences research has arrived with the launch of Biomni, a state-of-the-art AI agent…
Is NVIDIA’s 2025 Healthcare AI Report the Tipping…
Key Highlights Healthcare Sees Rapid ROI with Generative AIAccording to NVIDIA’s 2025 State of AI in Healthcare and…
Trending Posts
Latest Stories
Could GSK and Hengrui’s $12B Alliance Set a New Standard in China-Originated Drug Collaborations?
Key Highlights GSK Bets Big on Hengrui: A $12B Strategic Play Anchored in Respiratory InnovationIn…
Can Mandolin’s $40M VC Boost End Insurance Delays and Accelerate Access to Specialty Medications? What This Means for AI in Healthcare Delivery
Key Highlights: AI-Driven Innovation Tackling a Complex Healthcare BarrierSpecialty medications for cancer and neurodegenerative diseases…
Will Sanofi’s AI Ethics Revolution Trigger a $100 Billion Shift in Biopharma and Medtech? How the Company’s Transparency Drive is Reshaping Global Healthcare
Key Highlights: AI Ethics at Scale: Sanofi Sets Global Leadership StandardSanofi’s establishment of a dedicated…
Is Thermo Fisher’s $10B Q2 Surge the Inflection Point for AI-Powered Biopharma? How Will It Reshape the Life Sciences Landscape?
Key Highlights Financial Resilience and Strategic MarginsThermo Fisher Scientific’s Q2 2025 report showcases its fortress-like…
Gallery
